CN103804283A - Preparation method for 1, 2-dihydropyridine derivative - Google Patents

Preparation method for 1, 2-dihydropyridine derivative Download PDF

Info

Publication number
CN103804283A
CN103804283A CN201210439628.2A CN201210439628A CN103804283A CN 103804283 A CN103804283 A CN 103804283A CN 201210439628 A CN201210439628 A CN 201210439628A CN 103804283 A CN103804283 A CN 103804283A
Authority
CN
China
Prior art keywords
solvent
condition
alcohol
acid
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201210439628.2A
Other languages
Chinese (zh)
Other versions
CN103804283B (en
Inventor
万伯顺
信晓义
吴凡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN201210439628.2A priority Critical patent/CN103804283B/en
Publication of CN103804283A publication Critical patent/CN103804283A/en
Application granted granted Critical
Publication of CN103804283B publication Critical patent/CN103804283B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention relates to a preparation method for a 1, 2-dihydropyridine derivative, particularly a new method for preparation of the 1, 2-dihydropyridine derivative from a 3-aza-1, 5-eneyne derivative under the promotion (catalysis) of protonic acid through cyclization reaction. The method takes the 3-aza-1, 5-eneyne derivative as the raw material to generate the 1, 2-dihydropyridine derivative under two conditions. According to the condition A, alcohol is adopted as a solvent (also serving as a catalyst), other catalysts or additives are unnecessary, and reaction is carried out at a temperature ranging from room temperature to 140DEG C; or according to the condition B, alcohol, phenol or protonic acid is added into another organic solvent to serve as a catalyst. The yield of 1, 2-dihydropyridine derivative can reach up to 97%.

Description

One is prepared the method for 1,2-dihydrogen pyridine derivative
Technical field
The present invention relates to the preparation 1 that a kind of protonic acid promotes, the method for 2-dihydrogen pyridine derivative, specifically promotes (catalysis) 3-azepine-1 by alcohols, phenols or protonic acid, and 5-eneyne derivative generates the novel method of 1,2-dihydrogen pyridine derivative.
Background technology
Dihydropyridine is one of most important heterocycle, is not only the key structure unit of many natural products, organic materials and medicine, is also structure module very useful in organic synthesis.Because Isosorbide-5-Nitrae-dihydropyridine is as primary structure unit (document 1:(a) Kappe of a lot of medicines, C.O.Eur.J.Med.Chem.2000,35,1043; (b) Rampe, D.; Kane, J.M.Drug Dev.Res.1994,33,344; (c) Triggle, D.J.Cell.Mol.Neurobiol.2003,23,293; (d) Goldmann, S.; Stoltefuss, J.Angew.Chem., Int.Ed.1991,30,1559), thereby this compounds is studied (civilian 2:(a) Lavilla, R.J.Chem.Soc., PerkinsTrans.1.2002,1141 widely; (b) Gaudio, A.C.; Korolskovas, A.; Takahata, Y.J.Pharm.Sci.1994,83,1110).Relative, the research of 1,2-dihydrogen pyridine derivative relatively less (document 3:(a) Stout, D.M.; Meyers, A.I.Chem.Rev.1982,82,233; (b) Comins, D.L.; Hong, H.; Salvador, J.M.J.Org.Chem.1991,56,7197; (c) Ichikawa, E.; Suzuki, M.; Yabu, K.; Albert, M.; Kanai, M.; Shibasaki, M.J.Am.Chem.Soc.2004,126,11808.; (d) Brunner, B.; Stoigaitis, N.; Lautens, M.Org.Lett.2006,8,3473).The most frequently used method of synthesizing dihydro pyridine is the nucleophilic addition(Adn) of nucleophilic reagent to N-ethanoyl or N-Fixanol; the main drawback of these methods is severe reaction conditions; because nucleophilic species can add to the 2-of pyridinium salt; 4-or 6-position and often obtain multiple mixture (document 4:Bull, J.A.; Mousseau, J.J.; Pelletier, G.; Charette, A.B.Chem.Rev.2012,112,2642).Thereby the novel method of development synthetic 1,2-dihydropyridine of efficient green under mild conditions has great significance.Along with being on the increase of the substituting group pattern of this compounds, their physiologically active is studied, thereby more may to this compounds as drug provision.We have developed one and have not used metal catalyst, only promote synthetic 1, the 2-dihydrogen pyridine derivative novel method of (catalysis) with alcohols, phenols or protonic acid.Reaction conditions is simple, and yield is high, has very strong practicality.
Summary of the invention
The object of the present invention is to provide a kind of novel method of synthetic 1,2-dihydrogen pyridine derivative.
The present invention realizes by following measure:
(1) reference literature, synthesizes N-sulphonyl-allylamine through two steps: the first step, aromatic aldehyde and sulphonamide react and generate imines (document 5:Love, B.E. in ethyl orthosilicate; Raje, P.S.; Williams II, T.C.Synlett 1994,493.) (following formula 1, reaction equation 1); In the time that aldehyde is alkanoic, aldehyde, sulphonamide and SPTS are dissolved in formic acid and water and are reacted, obtain aliphatics imines (document 6:Chemla, F.; Hebbe, V.; Normant, J.F.Synthesis 2000,75.) (following formula, reaction equation 2).Second step, is added drop-wise to the tetrahydrofuran solution of alkynyl lithium at low temperatures reaction in the tetrahydrofuran solution of imines and obtains allyl amine solid (document 7:Katritzky, A.R.; Li, J.Q.; Gordeev, M.F.Synthesis 1994,93.) (following formula reaction equation 3).
Reaction equation 1
Figure BDA00002361427100021
Reaction equation 2
Reaction equation 3
Reaction equation 4
Figure BDA00002361427100024
Formula 1.3-azepine-1, the synthesis step of 5-eneyne derivative
(2) prepare class 3-azepine-1,5-eneyne.
Concrete operation step following (above formula 1, reaction equation 4):
In reactor, react, reactor vacuumizes after rear logical argon replaces three times, adds the new CH steaming of 40ml 2cl 2, then add N-sulphonyl-allylamine (III) of 5mmol and the alkynes (IV) of 5.5mmol, finally add the Cs of 5-20mol% 2cO 3, 0 ° of C-stirring at room temperature 4-24 hour; After reaction finishes, revolve that to evaporate partial solvent be the 1/4-1/5 that does not evaporate front liquor capacity to liquor capacity, loading is carried out silica gel column chromatography, and eluent is the mixed solvent of sherwood oil: ethyl acetate=10:1-5:1, obtain 3-azepine-1 of formula (I), 5-eneyne.
(3), by 3-azepine-1,5-eneyne derivative is prepared 1,2-dihydrogen pyridine derivative
Figure BDA00002361427100025
Formula 2.1,2-dihydrogen pyridine derivative synthetic
Reaction equation is shown in formula 2, in reactor, reacts, and reactor vacuumizes rear logical argon replaces three times.
Method A: add 3-azepine-1 of 0.2mmol, 5-eneyne (I), then adds 1-4mL alcohols, reaction under ° C of room temperature-140 is until raw material disappearance.After reaction finishes, revolve and evaporate after solvent, solid carries out silica gel column chromatography, obtains 1,2-dihydrogen pyridine derivative (II).
Method B: add 3-azepine-1 of 0.2mmol, 5-eneyne (I), then adds 0.5-5ml organic solvent, finally adds alcohol, phenol or the protonic acid of 5-95mol% to make catalyzer.Reaction under ° C of room temperature-140 is until raw material disappearance.After reaction finishes, revolve and evaporate after solvent, solid carries out silica gel column chromatography, obtains 1,2-dihydrogen pyridine derivative (II).
The present invention has following advantage:
1. reactant 3-azepine-1,5-eneyne is obtained through simple reaction step by raw material aldehyde, sulphonamide and Terminal Acetylenes cheap and easy to get and interior alkynes.
Generate 1, the operation of 2-dihydropyridine is simple; Do not use metal catalyst, environmental friendliness; Atom in reactant all appears in product, atom economy.
Embodiment
In order to understand better the present invention, describe by following instance.
Embodiment 1
Step 1 (raw materials Ia):
Figure BDA00002361427100031
In reactor, react, reactor vacuumizes after rear logical argon replaces three times, adds N-alkylsulfonyl-allylamine IIIa of 5mmol, adds the new CH steaming of 40mL 2cl 2, then add the alkynes IVa of 5.5mmol, finally add the Cs of 10mol% 2cO 3, stirring reaction 12 hours under 0 ° of C.After reaction finishes, revolve that to evaporate partial solvent to liquor capacity be not evaporate 1/5th of front liquor capacity, loading is carried out silica gel column chromatography, and eluent is the mixed solvent of sherwood oil: ethyl acetate=10:1, obtains 3-azepine-1,5-eneyne Ia.
The characterization data of Ia is as follows:
1H?NMR(400MHz,CDCl 3)δ7.92(d,J=8.3Hz,2H),7.64(d,J=7.7Hz,2H),7.40–7.27(m,8H),7.16(dd,J=8.1,1.4Hz,2H),6.54(s,1H),6.10(s,1H),3.76(s,3H),3.60(s,3H),2.31(s,3H); 13C?NMR(100MHz,CDCl 3)δ164.9,164.2,144.9,139.7,135.3,133.9,131.7,129.8,129.1,128.8,128.7,128.5,128.4,128.0,121.7,117.4,89.7,82.8,55.0,53.0,52.0,21.7;
HRMS?Calculated?for?C 28H 25NO 6NaS[M+Na] +526.1300,found?526.1300。
Step 2 (preparation 1,2-dihydropyridine IIa):
Figure BDA00002361427100032
In reactor, react, reactor vacuumizes rear logical argon replaces, adds 0.2mmol (100.7 mg) 3-azepine-1, and 5-eneyne Ia, then adds 2mL methyl alcohol, at lower 60 ℃ of argon shield, reacts 2 days.Take out after solvent with Rotary Evaporators, solid is dissolved in methylene dichloride loading and carries out silica gel column chromatography, with the eluent flushing pillar of sherwood oil: ethyl acetate=10:1, obtains 1 of 95.3mg, 2-dihydropyridine IIa, and separation yield is 95%.
The preparation IIa of amplification quantity: add 3.0mmol (1.5108g) Ia in 100mL reaction flask, then add 50mL methyl alcohol, (uncovered reaction) reaction 2 days under the atmosphere of air.Reaction finishes rear room temperature placement spends the night, and separates out solid 1.0374g.Solution with revolve steam be spin-dried for after, ethyl acetate for solid (3mL) and sherwood oil (15mL) recrystallization, obtain solid 0.3247g.Product total mass 1.3621g, separation yield 90%.
The sign number of IIa is as follows:
1H?NMR(400MHz,CDCl 3)δ7.80(d,J=8.1Hz,2H),7.47(d,J=7.4Hz,2H),7.34(m,5H),7.24(m,3H),6.80(d,J=7.1Hz,2H),5.86(d,J=6.2Hz,1H),5.67(d,J=6.2Hz,1H),3.80(s,3H),3.49(s,3H),2.42(s,3H);
13C?NMR(100MHz,CDCl 3)δ165.6,164.3,144.8,137.0,136.6,135.8,135.1,130.9,129.9,128.8,128.6,128.2,128.1,128.0,127.9,127.8,127.2,127.1,56.6,53.1,52.5,21.7;
HR?S?Calculated?for?C 28H 25NO 6NaS[M+Na] +526.1300,found?526.1308。
Embodiment 2
Figure BDA00002361427100041
In reactor, react, reactor vacuumizes rear logical argon replaces, adds 0.2mmol (100.7mg) 3-azepine-1,5-eneyne Ia, 1mL THF, then adds the Hydroquinone (Resorcinol of 0.02mmol, 10mol%), react 2 days at 60 ℃.Take out after solvent with Rotary Evaporators, solid is dissolved in methylene dichloride loading and carries out silica gel column chromatography, with the eluent flushing pillar of sherwood oil: ethyl acetate=10:1, obtains 1 of 95.7mg, 2-dihydropyridine IIa, and separation yield is 95%.
Embodiment 3
Figure BDA00002361427100042
In reactor, react, reactor vacuumizes rear logical argon replaces, adds 0.2mmol (104.3mg) 3-azepine-1, and 5-eneyne Ib, then adds 2mL methyl alcohol, at lower 60 ℃ of argon shield, reacts 2 days.Take out after solvent with Rotary Evaporators, solid is dissolved in methylene dichloride loading and carries out silica gel column chromatography, with the eluent flushing pillar of sherwood oil: ethyl acetate=10:1, obtains 1 of 91.9mg, 2-dihydropyridine IIb, and separation yield is 88%.
The characterization data of Ib is as follows:
1H?NMR(400MHz,CDCl 3)δ7.91(d,J=7.8Hz,2H),7.63(m,2H),7.32(m,5H),7.15(d,J=7.4Hz,2H),7.06(t,J=8.2Hz,2H),6.50(s,1H),6.12(s,1H),3.77(s,3H),3.63(s,3H),2.32(s,3H);
13C?NMR(100MHz,CDCl 3)δ164.8,164.2,162.9(d,J=244.7Hz),145.0,139.5,135.2,131.7,130.0,129.9,129.8,129.2,128.5,128.4,121.5,118.1,115.7(d,J=21.9Hz),89.8,82.7,54.4,53.1,52.2,21.7;
HRMS?Calculated?for?C 28H 24NO 6FNaS[M+Na] +544.1206,found?544.1205.
The characterization data of IIb is as follows:
1H?NMR(500MHz,CDCl 3)δ7.79(d,J=8.3Hz,2H),7.44(m,2H),7.32(d,J=8.0Hz,2H),7.24(m,3H),7.05(m,2H),6.80(m,2H),5.82(d,J=6.2Hz,1H),5.64(d,J=6.2Hz,1H),3.81(s,3H),3.50(s,3H),2.43(s,3H);
13C?NMR(125MHz,CDCl 3)δ165.5,164.2,163.0(d,J=247.3Hz),144.9,136.5,135.9,135.4,132.8,130.7,130.0,129.1,129.0,128.3,128.1,128.0,127.8,126.6,115.8(d,J=21.6Hz),55.9,53.1,52.5,21.7;
HRMS?Calculated?for?C 28H 24NO 6FNaS[M+Na] +544.1206,found?544.1210。

Claims (7)

1. prepare the method for 1,2-dihydrogen pyridine derivative for one kind, it is characterized in that:
With 3-azepine-1 shown in following formula, 5-eneyne (I) is that raw material generates 1,2-dihydrogen pyridine derivative (II) by ring-closure reaction, and reaction formula is as follows:
Figure FDA00002361427000011
Wherein R 1, R 2, R 3for the phenyl of C1-C8 alkyl, pyridyl, phenyl or replacement, the substituting group on phenyl is C1-C8 alkyl, C1-C8 alkoxyl group, F, Cl, Br, I, NO 2in one or two kinds or three kinds; R 1, R 5for C1-C4 ester group, phenyl, C1-C8 alkyl, alkylsulfonyl, trifluoromethyl, F, Cl, Br or I.
2. it is characterized in that in accordance with the method for claim 1:
In condition A, do the double catalyzer that does of solvent, the triol of the monohydroxy-alcohol that alcoholic solvent is C1-C10, the dibasic alcohol of C2-C10 or C3-C10 with alcohol.
3. it is characterized in that in accordance with the method for claim 1:
In condition B, make catalyzer with alcohols, phenols or protonic acid, make solvent with other organic solvent;
Organic solvent is one or two or more kinds in tetrahydrofuran (THF), DMF, benzene, tetracol phenixin, Isosorbide-5-Nitrae-dioxane, methylene dichloride, ethyl acetate or acetonitrile;
Consumption of organic solvent is every mmole reactant I solvent 1-20 milliliter.
4. it is characterized in that in accordance with the method for claim 3:
In condition B, monohydroxy-alcohol, the dibasic alcohol of C2-C10 or the triol of C3-C10 that the alcohols catalyzer that can use is C1-C10; Protonic acid is the one in the organic acid of C1-C10 or hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid; Phenol is phenol.
5. according to the method described in claim 1 or 2, it is characterized in that:
In condition A, the consumption of alcoholic solvent is every mmole reactant I solvent 5-20 milliliter.
6. according to the method described in claim 1 or 3, it is characterized in that:
In condition B, the consumption of alcohol, phenol or bronsted acid catalyst is the 5-95mol% of reactant I.
7. in accordance with the method for claim 1, it is characterized in that: no matter still use condition B with condition A, temperature of reaction is room temperature-140 ° C.
CN201210439628.2A 2012-11-06 2012-11-06 One prepares the method for 1,2-dihydrogen pyridine derivative Expired - Fee Related CN103804283B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210439628.2A CN103804283B (en) 2012-11-06 2012-11-06 One prepares the method for 1,2-dihydrogen pyridine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210439628.2A CN103804283B (en) 2012-11-06 2012-11-06 One prepares the method for 1,2-dihydrogen pyridine derivative

Publications (2)

Publication Number Publication Date
CN103804283A true CN103804283A (en) 2014-05-21
CN103804283B CN103804283B (en) 2016-04-20

Family

ID=50701722

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210439628.2A Expired - Fee Related CN103804283B (en) 2012-11-06 2012-11-06 One prepares the method for 1,2-dihydrogen pyridine derivative

Country Status (1)

Country Link
CN (1) CN103804283B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693593A (en) * 2014-11-25 2016-06-22 中国科学院大连化学物理研究所 Preparation method for 2-aza-dicyclo[3.2.0]-2-hexene derivative
CN110981802A (en) * 2019-12-10 2020-04-10 广东药科大学 Method for preparing nitrogen-containing heterocyclic compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130505A (en) * 1994-12-16 1996-09-11 拜尔公司 Use of 5-acyl-1,4-dihydropyridines
WO2004058148A2 (en) * 2002-12-20 2004-07-15 Merck & Co., Inc. Mitotic kinesin inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130505A (en) * 1994-12-16 1996-09-11 拜尔公司 Use of 5-acyl-1,4-dihydropyridines
WO2004058148A2 (en) * 2002-12-20 2004-07-15 Merck & Co., Inc. Mitotic kinesin inhibitors

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AKIO SAITO,等: "Synthesis of Pyrroles by Gold(I)-Catalyzed Amino−Claisen Rearrangement of N-Propargyl Enaminone Derivatives", 《ORGANIC LETTERS》 *
AKIO SAITO,等: "Synthesis of Pyrroles by Gold(I)-Catalyzed Amino−Claisen Rearrangement of N-Propargyl Enaminone Derivatives", 《ORGANIC LETTERS》, vol. 12, no. 2, 21 December 2009 (2009-12-21), pages 372 - 374 *
HAHN KIM,等: "Rhodium-Catalyzed Cycloisomerization of N-Propargyl Enamine Derivatives", 《J. AM. CHEM. SOC.》, vol. 128, 26 April 2006 (2006-04-26), pages 6336 - 6337 *
HIDETOMO IMASE,等: "Convergent and Rapid Assembly of Substituted 2-Pyridones through Formation of N-Alkenyl Alkynylamides Followed by Gold-Catalyzed Cycloisomerization", 《ORG. LETT.》, vol. 10, no. 16, 18 July 2008 (2008-07-18), pages 3563 - 3566 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693593A (en) * 2014-11-25 2016-06-22 中国科学院大连化学物理研究所 Preparation method for 2-aza-dicyclo[3.2.0]-2-hexene derivative
CN105693593B (en) * 2014-11-25 2018-06-12 中国科学院大连化学物理研究所 A kind of method for preparing 2- aza-bicyclos [3.2.0] -2- hexene derivatives
CN110981802A (en) * 2019-12-10 2020-04-10 广东药科大学 Method for preparing nitrogen-containing heterocyclic compound

Also Published As

Publication number Publication date
CN103804283B (en) 2016-04-20

Similar Documents

Publication Publication Date Title
Li et al. Rhodium (III)‐Catalyzed, C H Activated Annulation to Form Isocoumarins and α‐Pyrones using the O N Bond as an Internal Oxidant
Xu et al. Rhodium (III)-catalyzed selective access to isoindolinones via formal [4+ 1] annulation of arylamides and propargyl alcohols
Augustine et al. Propylphosphonic anhydride (T3P®): A remarkably efficient reagent for the one-pot transformation of aromatic, heteroaromatic, and aliphatic aldehydes to nitriles
Muthiah et al. Enantioselective synthesis of α-methylene-γ-butyrolactones using chiral Pd (II)-SPRIX catalyst
Kim et al. Synthesis of 1, 2, 5-and 1, 2, 3, 5-substituted pyrroles from substituted aziridines via Ag (I)-catalyzed intramolecular cyclization
Joy et al. A rapid approach for the copper, amine, and ligand-free Sonogashira coupling of 4-methyl-7-nonafluorobutylsulfonyloxy coumarins under microwave irradiation
Joy et al. Simultaneous exploration of TBAF· 3H2O as a base as well as a solvating agent for the palladium catalyzed Suzuki cross-coupling of 4-methyl-7-nonafluorobutylsulfonyloxy coumarins under microwave irradiation
CN101337966B (en) Method for preparing high-purity irinotecan
He et al. One-pot cascade reactions of 1-arylpenta-3, 4-dien-2-ones leading to 2-arylphenols and dibenzopyroanones
Chai et al. N‐Heterocyclic Carbene‐catalyzed Reactions of o‐Aminonitriles with Carbonyl Compounds Approach to 2, 3‐Dihydroquinazolin‐4 (1H)‐ones
Jia et al. Organocatalytic [4+ 2] cyclocondensation of α, β-unsaturated acyl chlorides with imines: highly enantioselective synthesis of dihydropyridinone and piperidine derivatives
CN103694204B (en) 1,2,4-trisubstituent furan compound and preparation method thereof
Mohammadzadeh et al. A convenient one-pot synthesis of new chromeno [3, 4-c] chromene and chromeno [3, 4-c] pyridine derivatives in the presence of high surface area of magnesium oxide
Du et al. Proline potassium salt: a superior catalyst to synthesize 4-trifluoromethyl quinoline derivatives via Friedlander annulation
CN103159662A (en) Method for preparing pyrrole derivative with sulfonyl group on beta-substituent
CN107286092B (en) Method for preparing isoquinoline diketone by carbon-hydrogen functionalization of methoxybenzamide and diazo ester
Pearson et al. Synthesis of a potential intermediate for TMC-95A via an organocatalyzed aldol reaction
Shi et al. Highly Regioselective DABCO‐Catalyzed Nucleophilic Aromatic Substitution (SNAr) Reaction of Methyl 2, 6‐Dichloronicotinate with Phenols
CN103804283B (en) One prepares the method for 1,2-dihydrogen pyridine derivative
CN106146334A (en) 2,3-diaryl-2-propargyl amide groups-3-arylamino methyl propionate derivant and its preparation method and application
Nordmann et al. Anilines as Substrates in Consecutive Four-Component Synthesis of Novel 1-Aryl-5-benzoyl-6-phenyl-3, 4-dihydropyridin-2 (1H)-ones
CN103420901B (en) Preparation method for 1,2-dihydropyridine derivatives
CN105017238A (en) Method for chiral spirophosphonate catalyzed synthesis of optically active 2H-1,4-benzoxazine-2-one derivative
Kim et al. An expedient synthesis of poly-substituted 1-arylisoquinolines from δ-ketonitriles via indium-mediated Barbier reaction protocol
Yang et al. An easy direct arylation of 3-arylsydnones

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160420

Termination date: 20181106

CF01 Termination of patent right due to non-payment of annual fee